Non-standard PET radionuclides: Time to get ready for new clinical PET strategies

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 34, Issue 2, 2007, Pages 294-300

  Lucignani, Giovanni ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ACETIC ACID DERIVATIVE; BISMUTH 213; BOMBESIN; COPPER 64; COPPER DIACETYLBIS(N4 METHYLTHIOSEMICARBAZONE); CYCLOHEXYLDIETHYLENETRIAMINEPENTAACETIC ACID; EPIDERMAL GROWTH FACTOR; FLUORODEOXYGLUCOSE; GASTRIN RELEASING PEPTIDE RECEPTOR; HAPTEN ANTIBODY; IODINE 123; IODINE 124; NICKEL; OCTREOTIDE; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT; SODIUM IODIDE SYMPORTER; TECHNETIUM 94M; TRACER; UNCLASSIFIED DRUG; YTTRIUM 86; ZINC 64; ZINC 65; ZINC 69;

COMPUTER ASSISTED TOMOGRAPHY; CYCLOTRON; DEUTERON NUCLEAR MAGNETIC RESONANCE; FEASIBILITY STUDY; GENE EXPRESSION; GENE THERAPY; HUMAN; HYPOXIA; IMAGE QUALITY; ISOTOPE LABELING; MAMMOGRAPHY; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; RADIODIAGNOSIS; REVIEW; TUMOR XENOGRAFT;

IMAGE ENHANCEMENT; ISOTOPE LABELING; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 33846463459     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-006-0330-0     Document Type: Review

References (17)

1. BIO-TECH Report #240, The Market for PET Radiopharmaceuticals & PET Imaging. http://www.biotechsystems.com/reports/240/default.asp.
2. Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med 1997;24(10):1301-27.
3. 124I reaction. Appl Radiat Isot 2006;64(9):965-70.
4. 64Zn. Appl Radiat Isot 2006;64(9):1001-5.
5. Fan X, Parker DJ, Smith MD, Ingram A, Yang Z, Seville JP. A simple and selective method for the separation of Cu radioisotopes from nickel. Nucl Med Biol 2006;33(7):939-44.
6. Bigott HM, Laforest R, Liu X, Ruangma A, Wuest F, Welch MJ. Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol 2006;33(7):923-33.
7. Clifford T, Boswell CA, Biddlecombe GB, Lewis JS, Brechbiel MW. Validation of a novel CHX-A″ derivative suitable for peptide conjugation: small animal PET/CT imaging using yttrium-86-CHX-A″-octreotide. J Med Chem 2006;49(14):4297-304.
8. Dingli D, Kemp BJ, O'Connor MK, Morris JC, Russell SJ, Lowe VJ. Combined I-124 positron emission tomography/ computed tomography imaging of NIS gene expression in animal models of stably transfected and intravenously transfected tumor. Mol Imaging Biol 2006;8(1):16-23.
9. 124I-labeled small molecular tracer and positron emission tomography. Mol Imaging Biol 2006;8(5):262-77.
10. 124I- labeled hapten-peptide. J Nucl Med 2006;47(10):1678-88.
11. Parry JJ, Andrews R, Rogers BE. MicroPET imaging of breast cancer using radiolabeled bombesin analogs targeting the gastrin-releasing peptide receptor. Breast Cancer Res Treat 2006; Jul 13; [Epub ahead of print].
12. 2. J Nucl Med 2006;47(10):1649-52.
13. 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med 2006;47(6):989-98.
14. 60Cu-ATSM: relationship to therapeutic response - a preliminary report. Int J Radiat Oncol Biol Phys 2003;55(5):1233-8.
15. 60Cu- ATSM. Eur J Nucl Med Mol Imaging 2003;30:844-50.
16. 131I. J Nucl Med 2006;47(8):1375-81.
17. 124I]AM281 PET demonstrated in a schizophrenic patient. Psychiatry Res 2006;147(2-3):249-56.